Biomarker tests for decision-making on chemotherapy for breast cancer: No evidence of transferability

(Institute for Quality and Efficiency in Health Care) Biomarker tests for decision-making on chemotherapy for breast cancer: No evidence of transferability27.02.2020 The tests assign different women to the group 'low risk of recurrence.' It thus remains unclear who could omit chemotherapy.